Health
Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine – News-Medical.Net
In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in…
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases caused by zoonotic betacoronaviruses have caused serious outbreaks in the last two decades. Even as vaccines are administered globally to minimize the infection and severity of the disease, the emergence of circulating variants of concern (VOC) has raised concerns for sustained vaccine efficacy.
The receptor-binding domain (RBD) of the virus’s…
-
General24 hours agoTrump’s tariffs: a bad idea executed badly
-
Business4 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Business11 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News6 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed